Type 2 diabetes among Sudanese youth: Rate, pattern of prescription, comorbidities, and clinical inertia

Table 1 Basic characteristics of the study group

Character	Range	mean ± SD
Age	22-82	55.24 ± 10.57
Body mass index	18.0-45	30.09 ± 4.65
Duration of diabetes	1-40	10.64 ± 8.23
HbA1c	5.9-15.6	9.37 ± 2.49

HbA1c: Glycated hemoglobin.

Table 2 Basic characteristics of patients with type 2 diabetes < 40 years

Character	Range	mean ± SD
Age	30-39	36.5 ± 2.9
Body mass index	25-35	31.0 ± 2.4
Duration of diabetes	1-15	5.8 ± 3.7
HbA1c	7-12	9.6 ± 1.1

HbA1c: Glycated hemoglobin.

Table 3 Medications and comorbidities among patients with diabetes

Character	n (%)
Metformin	164 (68.3)
Sulphonylureas	128 (53.3)
Pioglitazone	26 (10.8)
Insulin	118 (49.2)
Anti-hypertensive drugs	136 (56.7)
Lipid-lowering	120 (50)
Sex, females	154 (64.2) 87.5% in the young
Young age	59 (24.6)
Dyslipidemia	139 (57.9)

Table 4 The association between gender, age, body mass index, and glycated hemoglobin

Character	B	S.E.	Wald	df	Sig.	Exp (B)	95%CI for EXP(B)
Age	-0.057	0.039	2.129	1	0.145	0.945	0.875 to 1.020
HbA1c	-0.036	0.033	1.200	1	0.273	0.964	0.903 to 1.029
BMI	0.064	0.054	1.416	1	0.234	1.067	0.959 to 1.186
Constant	1.948	2.437	0.639	1	0.424	7.017

Binary Logistic Regression Analysis. HbA1c: Glycated hemoglobin; BMI: Body mass index.